Seeing Is Believing
Currently out of the existing stock ratings of Luke Sergott, 72 are a HOLD (19.15%), 251 are a BUY (66.76%), 53 are a SELL (14.1%).
Analyst Luke Sergott, currently employed at BARCLAYS, carries an average stock price target met ratio of 65.81% that have a potential upside of 14.95% achieved within 110 days.
Luke Sergott’s has documented 793 price targets and ratings displayed on 29 stocks. The coverage is on Basic Materials, Healthcare sectors.
Most recent stock forecast was given on AVTR, Avantor at 06-Mar-2026.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for SHC (SOTERA HEALTH CO) at 11/15/2022. The price target of $6 was fulfilled within 2 days with a profit of $0.97 (13.92%) receiving and performance score of 69.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Oct-2025
$8.5
$-0.02 (-0.23%)
$9
4 days ago
(06-Mar-2026)
17/29 (58.62%)
$-0.02 (-0.23%)
115
Buy Since 11-Jun-2019
$14
$5.48 (64.32%)
$16
25 days ago
(13-Feb-2026)
2/7 (28.57%)
$4.8 (52.17%)
255
Hold Since 05-Jan-2026
$12
$3.48 (40.85%)
$14
2 months 5 days ago
(05-Jan-2026)
5/11 (45.45%)
$0.11 (0.93%)
22
Sell Since 17-Dec-2025
$9
$0.48 (5.63%)
$55
2 months 21 days ago
(17-Dec-2025)
5/6 (83.33%)
$-2.1 (-18.92%)
152
Buy Since 30-Aug-2021
$16
$7.48 (87.79%)
$14
4 months 22 days ago
(16-Oct-2025)
6/15 (40%)
$1.43 (9.81%)
256
Which stock is Luke Sergott is most bullish on?
Which stock is Luke Sergott is most reserved on?
What Year was the first public recommendation made by Luke Sergott?